Drug Profile
Research programme: monoamine oxidase B inhibitors - Dart NeuroScience
Latest Information Update: 03 Dec 2015
Price :
$50
*
At a glance
- Originator Helicon Therapeutics
- Developer Dart NeuroScience
- Class Isoxazoles
- Mechanism of Action Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurodegenerative disorders
Most Recent Events
- 03 Dec 2015 Discontinued for Neurodegenerative disorders in USA (unspecified route)
- 13 Apr 2015 Early research in Neurodegenerative disorders in USA (unspecified route)